Bénedicte Laglenne

Title: Bénedicte Laglenne: Innovator in Aesthetic Dermatology

Introduction

Bénedicte Laglenne is a notable inventor based in Mauguio, France. He has made significant contributions to the field of aesthetic dermatology through his innovative inventions. His work focuses on improving techniques for subcutaneous and intradermal injections, which are essential in various medical and cosmetic applications.

Latest Patents

Bénedicte Laglenne holds a patent for an "Implant for subcutaneous or intradermal injection." This invention addresses the need for effective solutions in filling wrinkles, thin lines, skin cracks, and scars. It is particularly relevant for reparative or plastic surgery, aesthetic dermatology, and dental treatments. The implant utilizes biologically absorbable polymer microspheres or microparticles suspended in a gel. This suspension can be produced either ready-for-use or freeze-dried. The biological absorbability of the microspheres is carefully controlled, allowing for the creation of implants with a defined persistence, limited to three years.

Career Highlights

Bénedicte Laglenne is associated with Aventis Pharmaceuticals Holdings, Inc., where he applies his expertise in developing innovative medical solutions. His work has contributed to advancements in the field, particularly in enhancing patient outcomes in aesthetic procedures.

Collaborations

Throughout his career, Bénedicte has collaborated with notable professionals, including Jérôme Asius and Hatem Fessi. These collaborations have fostered a productive environment for innovation and development in their respective fields.

Conclusion

Bénedicte Laglenne's contributions to aesthetic dermatology through his patented inventions highlight his role as a key innovator in the industry. His work continues to influence practices in medical and cosmetic treatments, showcasing the importance of innovation in improving patient care.